Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., Ltd (HKPD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HKPD · as of Jun 8, 2026
Key Statistics
Explore Cellyan Biotechnology Co., Ltd Data
hkpd stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hkpd competitorsHKPD
ARTW
ATXG
CRGO
JYD
LSHStock Performance
Full HistoryAbout Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., Ltd an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cr…
what is cellyan biotechnology co., ltd · hkpd stock overview · cellyan biotechnology co., ltd company profile · who is cellyan biotechnology co., ltd ceo · hkpd NASDAQ · cellyan biotechnology co., ltd headquarters · cellyan biotechnology co., ltd business segments
About Stock Overview & Key Data
Cellyan Biotechnology Co., Ltd (HKPD) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on NASDAQ since Jan 15, 2025. As of the latest trading session, HKPD stock price is $0.49, with a market capitalization of $5.4M. The stock has returned -76.99% over the past 12 months and -39.98% year-to-date.
In fiscal year 2025, Cellyan Biotechnology Co., Ltd reported revenue of $20.3M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cellyan Biotechnology Co., Ltd (HKPD) stock price is $0.49. The stock is traded on NASDAQ under the ticker symbol HKPD. The 52-week range is $0.37 – $2.58.